Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AXV3
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0005488 | binding | 1 | 12 |
GO:0008270 | zinc ion binding | 6 | 9 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0046914 | transition metal ion binding | 5 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 274 | 278 | PF00656 | 0.565 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.318 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.434 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.407 |
CLV_NRD_NRD_1 | 247 | 249 | PF00675 | 0.477 |
CLV_PCSK_FUR_1 | 243 | 247 | PF00082 | 0.523 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.434 |
CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.391 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.409 |
CLV_PCSK_KEX2_1 | 245 | 247 | PF00082 | 0.392 |
CLV_PCSK_PC1ET2_1 | 232 | 234 | PF00082 | 0.504 |
CLV_PCSK_PC1ET2_1 | 245 | 247 | PF00082 | 0.378 |
CLV_PCSK_PC7_1 | 243 | 249 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 329 | 333 | PF00082 | 0.261 |
CLV_Separin_Metazoa | 293 | 297 | PF03568 | 0.665 |
DOC_PP4_FxxP_1 | 322 | 325 | PF00568 | 0.510 |
DOC_USP7_UBL2_3 | 168 | 172 | PF12436 | 0.445 |
DOC_USP7_UBL2_3 | 328 | 332 | PF12436 | 0.443 |
DOC_USP7_UBL2_3 | 345 | 349 | PF12436 | 0.451 |
LIG_14-3-3_CanoR_1 | 157 | 163 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 17 | 22 | PF00244 | 0.308 |
LIG_14-3-3_CanoR_1 | 202 | 208 | PF00244 | 0.457 |
LIG_deltaCOP1_diTrp_1 | 145 | 152 | PF00928 | 0.494 |
LIG_FHA_2 | 18 | 24 | PF00498 | 0.369 |
LIG_LIR_Gen_1 | 113 | 123 | PF02991 | 0.235 |
LIG_LIR_Gen_1 | 143 | 153 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 20 | 28 | PF02991 | 0.387 |
LIG_LIR_Gen_1 | 305 | 315 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 108 | 114 | PF02991 | 0.409 |
LIG_LIR_Nem_3 | 133 | 139 | PF02991 | 0.384 |
LIG_LIR_Nem_3 | 143 | 149 | PF02991 | 0.412 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 20 | 24 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 305 | 311 | PF02991 | 0.597 |
LIG_Pex14_1 | 167 | 171 | PF04695 | 0.439 |
LIG_Pex14_2 | 152 | 156 | PF04695 | 0.354 |
LIG_SH2_CRK | 115 | 119 | PF00017 | 0.374 |
LIG_SH2_CRK | 58 | 62 | PF00017 | 0.302 |
LIG_SH2_SRC | 21 | 24 | PF00017 | 0.422 |
LIG_SH2_STAP1 | 180 | 184 | PF00017 | 0.567 |
LIG_SH2_STAT3 | 41 | 44 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.402 |
LIG_SUMO_SIM_par_1 | 11 | 16 | PF11976 | 0.359 |
LIG_TRAF2_1 | 263 | 266 | PF00917 | 0.500 |
LIG_TYR_ITSM | 111 | 118 | PF00017 | 0.458 |
LIG_UBA3_1 | 280 | 287 | PF00899 | 0.578 |
LIG_WRC_WIRS_1 | 162 | 167 | PF05994 | 0.439 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.363 |
MOD_CK2_1 | 17 | 23 | PF00069 | 0.320 |
MOD_CK2_1 | 276 | 282 | PF00069 | 0.601 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.482 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.466 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.483 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.505 |
MOD_GSK3_1 | 368 | 375 | PF00069 | 0.692 |
MOD_LATS_1 | 155 | 161 | PF00433 | 0.392 |
MOD_N-GLC_1 | 157 | 162 | PF02516 | 0.388 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.421 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.628 |
MOD_NEK2_2 | 110 | 115 | PF00069 | 0.370 |
MOD_PKA_1 | 17 | 23 | PF00069 | 0.302 |
MOD_PKA_1 | 29 | 35 | PF00069 | 0.302 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.446 |
MOD_PKA_2 | 288 | 294 | PF00069 | 0.586 |
MOD_Plk_1 | 157 | 163 | PF00069 | 0.395 |
MOD_Plk_1 | 358 | 364 | PF00069 | 0.446 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.379 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.669 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.369 |
MOD_SUMO_for_1 | 196 | 199 | PF00179 | 0.444 |
MOD_SUMO_for_1 | 218 | 221 | PF00179 | 0.514 |
MOD_SUMO_for_1 | 331 | 334 | PF00179 | 0.387 |
MOD_SUMO_rev_2 | 11 | 20 | PF00179 | 0.302 |
MOD_SUMO_rev_2 | 166 | 173 | PF00179 | 0.426 |
TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.401 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.534 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.348 |
TRG_ENDOCYTIC_2 | 9 | 12 | PF00928 | 0.303 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.414 |
TRG_ER_diArg_1 | 182 | 184 | PF00400 | 0.463 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.416 |
TRG_ER_diArg_1 | 246 | 248 | PF00400 | 0.473 |
TRG_NLS_Bipartite_1 | 17 | 33 | PF00514 | 0.422 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE61 | Leptomonas seymouri | 87% | 100% |
A0A0S4J1C8 | Bodo saltans | 54% | 81% |
A0A1X0NZG6 | Trypanosomatidae | 62% | 100% |
A0A3Q8IDF1 | Leishmania donovani | 95% | 100% |
A0A422P4I6 | Trypanosoma rangeli | 59% | 100% |
A4HEC3 | Leishmania braziliensis | 92% | 100% |
A4I1R8 | Leishmania infantum | 96% | 100% |
C9ZKC5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 100% |
E9Q8D0 | Mus musculus | 40% | 71% |
O14213 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 99% |
Q0II91 | Bos taurus | 39% | 71% |
Q4Q9L8 | Leishmania major | 94% | 100% |
Q5F1R6 | Homo sapiens | 39% | 71% |
Q6PGY5 | Danio rerio | 37% | 69% |
V5ASJ0 | Trypanosoma cruzi | 58% | 100% |